News
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results